{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:11:35Z","timestamp":1754111495026,"version":"3.40.2"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2022R1F1A1067609"],"award-info":[{"award-number":["2022R1F1A1067609"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05367-x","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T10:58:40Z","timestamp":1742641120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Influence of SARS-CoV-2 variants and corticosteroid use on the effectiveness of baricitinib therapy in critical COVID-19"],"prefix":"10.1186","volume":"29","author":[{"given":"Seung-Hun","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Seong","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"5367_CR1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s13054-024-05187-5","volume":"28","author":"R Li","year":"2024","unstructured":"Li R, Wang J, Li Q, Guo Q, Zhao JK, Wei JC, et al. Comments on \u201cBaricitinib versus tocilizumab in mechanically ventilated patients with COVID-19: a nationwide cohort study.\u201d Crit Care. 2024;28:428.","journal-title":"Crit Care"},{"key":"5367_CR2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13054-024-05063-2","volume":"28","author":"SH You","year":"2024","unstructured":"You SH, Baek MS, Kim TW, Jung SY, Kim WY. Baricitinib versus tocilizumab in mechanically ventilated patients with COVID-19: a nationwide cohort study. Crit Care. 2024;28:282.","journal-title":"Crit Care"},{"key":"5367_CR3","doi-asserted-by":"crossref","first-page":"ofad26","DOI":"10.1093\/ofid\/ofad426","volume":"10","author":"S Sunny","year":"2023","unstructured":"Sunny S, Tran A, Lee J, Abdallah M, Chaudhry N, Quale J. Comparison of tocilizumab vs baricitinib in clinical outcomes among hospitalized patients with COVID-19: experience from a public hospital system in New York City. Open Forum Infect Dis. 2023;10:ofad26.","journal-title":"Open Forum Infect Dis"},{"key":"5367_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","volume":"63","author":"AW Meikle","year":"1977","unstructured":"Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977;63:200\u201327.","journal-title":"Am J Med"},{"key":"5367_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/CCM.0000000000005756","volume":"51","author":"JH Peterson","year":"2023","unstructured":"Peterson JH, Paranjape NS, Grundlingh N, Priestley JL. Outcomes and adverse effects of baricitinib versus tocilizumab in the management of severe COVID-19. Crit Care Med. 2023;51:337\u201346.","journal-title":"Crit Care Med"},{"key":"5367_CR6","unstructured":"National Medical Center\u2014Office for the Central Infectious Disease Hospital\u2014National Institute of Infectious Diseases. Clinical practice guideline for coronavirus disease 2019 (COVID-19). https:\/\/www.nmc.or.kr\/icd\/bbs\/B0000070\/list.do?menuNo=1300032 (2022). Accessed 12 Apr 2024."},{"key":"5367_CR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(22)01109-6","volume":"400","author":"RECOVERY Collaborative Group","year":"2022","unstructured":"RECOVERY Collaborative Group. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet. 2022;400:359\u201368.","journal-title":"Lancet"},{"key":"5367_CR8","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/CCM.0000000000006444","volume":"53","author":"AE Patanwala","year":"2025","unstructured":"Patanwala AE, Xiao X, Hills TE, Higgins AM, McArthur CJ, Alexander GC, et al. Comparative effectiveness of baricitinib versus tocilizumab in hospitalized patients with COVID-19: a retrospective cohort study of the National Covid Collaborative. Crit Care Med. 2025;53:e29-41.","journal-title":"Crit Care Med"},{"key":"5367_CR9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00134-013-2831-1","volume":"39","author":"A Reintam Blaser","year":"2013","unstructured":"Reintam Blaser A, Poeze M, Malbrain ML, Bjorck M, Oudemans-van Straaten HM, Starkopf J, et al. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study. Intens Care Med. 2013;39:899\u2013909.","journal-title":"Intens Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05367-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05367-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05367-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T10:59:10Z","timestamp":1742641150000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05367-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5367"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05367-x","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol for the utilization of de-identified patient data was exempt from review by the Institutional Review Board of Chung-Ang University (1041078-20230306-HR-055).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}